This evidence-based review evaluates the usefulness of evoked potentials in identifying clinically silent lesions in patients with suspected multiple sclerosis.
Suspected multiple sclerosis
Evoked potentials (EPs)
Identification of clinically silent lesions
The Quality Standards Subcommittee of the American Academy of Neurology (AAN) is charged with developing practice parameters for neurologists for diagnostic procedures, treatment modalities, and clinical disorders. The selection of topics for which practice parameters are used is based on prevalence, frequency of use, economic impact, membership involvement, controversy, urgency, external constraints, and resources required. This article addresses the usefulness of evoked potentials (EPs) in identifying clinically silent lesions in patients with suspected MS.
Building similarity graph...
Analyzing shared references across papers
Loading...
Gary Gronseth
University of Kansas Medical Center
Eric Ashman
American Academy of Neurology
Neurology
American Academy of Neurology
Building similarity graph...
Analyzing shared references across papers
Loading...
Gronseth et al. (Tue,) conducted a review in Suspected multiple sclerosis. Evoked potentials (EPs) was evaluated on Identification of clinically silent lesions. This evidence-based review evaluates the usefulness of evoked potentials in identifying clinically silent lesions in patients with suspected multiple sclerosis.
synapsesocial.com/papers/6a0c737ee28175e95a235725 — DOI: https://doi.org/10.1212/wnl.54.9.1720
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: